Navigation Links
ULURU Inc. Announces First Order Of Altrazeal For European Launch
Date:9/20/2012

CEO of ULURU Inc., added, "We are very pleased not only with the progress in Europe but also with the outstanding group of opinion leaders that have been assembled to support the commercialization of Altrazeal® throughout the region. The necessary pre-marketing activities to ensure a successful launch are being conducted which gives us great confidence that Altrazeal® will be a significant competitor in the advanced wound care market."

Altrazeal® is an advanced scientifically engineered material that is unique among all other wound dressings in terms of properties and performance. It incorporates the features and benefits of the desired "ideal" wound dressing. Altrazeal® has demonstrated potential clinical and economic advantages in a number of chronic and acute wounds including diabetic foot ulcers, venous leg ulcers, pressure ulcer, and geriatric wounds.

About ULURU Inc.:
ULURU Inc. is a specialty pharmaceutical company focused on the development of a portfolio of wound management and oral care products to provide patients and consumers improved clinical outcomes through controlled delivery utilizing its innovative Nanoflex® Aggregate technology and OraDisc™ transmucosal delivery system.  For further information about ULURU Inc., please visit our website at www.uluruinc.com.  For further information about Altrazeal®, please visit www.Altrazeal.com.

This press release contains certain statements that are forward-looking within the meaning of Section 27a of the Securities Act of 1933, as amended.  These statements are subject to numerous risks and uncertainties, including but not limited to our belief that Altrazeal® will be a major competitor in the wound care market, anticipated product launches in Austria, the cost effectivene
'/>"/>

SOURCE ULURU Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. ULURU Inc. Reports Second Quarter 2012 Financial Results
2. ULURU Inc. Announces Completion Of $2.2mil Convertible Debt Offering
3. United Therapeutics Announces Collaboration With Ascendis Pharma To Develop Self-Injectable Treprostinil For Pulmonary Arterial Hypertension
4. FDAnews announces Third Annual Pharmaceutical Labeling Summit
5. CVS Caremark Corporation Announces New Share Repurchase Authorization for up to $6 Billion of Common Stock
6. PRN Physician Recommended Nutriceuticals announces partnership with Dr. Eric Donnenfeld and expansion in the New York City metropolitan area
7. InnoPharma, Inc., Announces U.S. FDA Approval of Acetylcysteine Solution, USP, 20% for Inhalation or Oral Administration
8. Specialty Pharmacy Certification Board Announces Inaugural Board of Directors
9. Valeant Pharmaceuticals Announces Launch of Concurrent Private Offerings of Senior Notes
10. Golden Meditech Holdings Limited Announces Updates on Medical Devices Subsidiary Latest Development
11. Active Life Announces Launch of Next Generation BioDentTM for Life Science Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... , Aug. 27, 2015  Eli Lilly and Company ... Global Healthcare Conference on Thursday, September 17, 2015. ... of Lilly Oncology and Richard Gaynor , M.D., ... for Lilly Oncology, will participate in a fireside chat ... A live audio webcast will be available on the ...
(Date:8/27/2015)... 27, 2015  A mere one in seven new ... Hamilton . A new white paper from ... impeding and disrupting manufacturers, success. The white ... Value In Product Development Processes provides insight into: ... how it affects the product development process resulting in: ...
(Date:8/27/2015)... and TORONTO , Aug. 27, 2015 ... today announced the issuance of a white paper on ... insulin spray product.  The white paper was presented to ... stockholders by Dr. James H. Anderson, Jr. , ... may be viewed online on the Generex website. ...
Breaking Medicine Technology:Lilly to Participate in Morgan Stanley Global Healthcare Conference 2New White Paper Reveals How Manufacturers Can Improve Product Development Processes 2Generex Announces Issuance of Buccal Insulin White Paper 2Generex Announces Issuance of Buccal Insulin White Paper 3Generex Announces Issuance of Buccal Insulin White Paper 4
... Calif., March 24 NuRx,Pharmaceuticals, Inc. (OTC Bulletin Board: ... a Phase I clinical trial of the first-in-class,rexinoid receptor ... expects to complete in the fourth,quarter of this year, ... compound. NRX4204 is the company,s first drug candidate in ...
... March 22 Issue of The Lancet -, ... announced that efficacy results of the randomized ... the March 22 issue of The Lancet ... in,combination with 5-fluorouracil/leucovorin (5-FU/LV), a chemotherapy,regimen called ...
Cached Medicine Technology:NuRx Pharmaceuticals Doses First Patient in Phase I Clinical Trial of First-in-Class RXR Agonist NRX4204 2Perioperative Eloxatin(R)-Based Regimen Significantly Reduced the Risk of Relapse Versus Surgery Alone in Eligible Colorectal Cancer Patients with Initially Resectable Liver Metastases 2Perioperative Eloxatin(R)-Based Regimen Significantly Reduced the Risk of Relapse Versus Surgery Alone in Eligible Colorectal Cancer Patients with Initially Resectable Liver Metastases 3Perioperative Eloxatin(R)-Based Regimen Significantly Reduced the Risk of Relapse Versus Surgery Alone in Eligible Colorectal Cancer Patients with Initially Resectable Liver Metastases 4Perioperative Eloxatin(R)-Based Regimen Significantly Reduced the Risk of Relapse Versus Surgery Alone in Eligible Colorectal Cancer Patients with Initially Resectable Liver Metastases 5
(Date:8/27/2015)... ... August 27, 2015 , ... ... that its Krames Patient Education content is ICD-10 ready and available to all ... the new ICD-10 code sets, which are more targeted and return a more ...
(Date:8/27/2015)... ... 2015 , ... In addition to its existing Doctor of Philosophy in Leadership ... at its main campus in Reading: Doctor of Nursing Practice. , Alvernia’s Doctor ... practice nurses for the highest level of clinical nursing practice. , “Our vision ...
(Date:8/27/2015)... ... August 27, 2015 , ... ... Analysis signed a partnership agreement for quality market research promotion on the ... by Black Swan Analysis. , Commenting on the partnership agreement, Natalie Aster, ...
(Date:8/27/2015)... ... ... Sunbelt® Bakery, maker of delicious granola snacks that have a bakery-fresh taste with ... bars should taste with the launch of its new line of protein bars that ... , The new Protein Delights are individually wrapped wafer bars that also contain ...
(Date:8/27/2015)... Ca (PRWEB) , ... August 27, 2015 , ... ... Southern California including Los Angeles, Riverside, San Bernardino, and Orange County. ... Healthpointe’s executive physical exams are offered annually at all of its locations. ...
Breaking Medicine News(10 mins):Health News:StayWell announces all health content is ICD-10 ready 2Health News:StayWell announces all health content is ICD-10 ready 3Health News:Alvernia University Now Offering Three Doctoral Degree Programs 2Health News:Market Publishers Ltd and Black Swan Analysis Sign Partnership Agreement 2Health News:Market Publishers Ltd and Black Swan Analysis Sign Partnership Agreement 3Health News:Sunbelt® Bakery Changes the Expectations of How Protein Bars Should Taste with the Introduction of Its New Protein Delights 2Health News:Sunbelt® Bakery Changes the Expectations of How Protein Bars Should Taste with the Introduction of Its New Protein Delights 3Health News:Healthpointe Now Offering Executive Physicals 2
... , , OAKLAND, ... of Medical Directors of Information Systems Award in recognition of ... The award is based on successful implementation of a technology ... practice and to improve work flow and contain health costs. ...
... WOODCLIFF LAKE, N.J., July 15 Par Pharmaceutical Companies, Inc. (NYSE: ... webcast on Tuesday, August 4, 2009 at 9:00 am EDT to review results ... financial results on August 4 before the market opens. The earnings release will ... , Access to the live webcast can be ...
... , AMSTERDAM and SAN DIEGO, July 15 Royal ... it has reached an agreement to acquire the assets of InnerCool ... involves the management of a patient,s body temperature. InnerCool, a wholly-owned ... will be acquired in an asset purchase transaction for US $11.25M, ...
... WESTFORD, Mass., July 15 Cynosure, Inc. ... of a broad array of light-based aesthetic treatment systems, today announced ... Tuesday, July 28, 2009 at 9:00 a.m. ET. , ... Officer Michael Davin and Executive Vice President and Chief Financial Officer ...
... , , , ... Inc. (NYSE: WPI ), a leading specialty pharmaceutical ... has filed an Abbreviated New Drug Application (ANDA) with the ... trospium chloride extended-release 60 mg capsules prior to the expiration ...
... , , , ... HealthLeaders-InterStudy and Fingertip Formulary find that surveyed pharmacy directors ... immune biologics will shift from a medical benefit to a ... UCB,s Cimzia among products that will be most affected by ...
Cached Medicine News:Health News:Kaiser Permanente Wins National Award for Technology-Supported Patient Care and Efficiency 2Health News:Kaiser Permanente Wins National Award for Technology-Supported Patient Care and Efficiency 3Health News:Philips Expands Emergency Healthcare Offering With Acquisition of InnerCool Therapies, a Leader in Body Temperature Management 2Health News:Philips Expands Emergency Healthcare Offering With Acquisition of InnerCool Therapies, a Leader in Body Temperature Management 3Health News:Cynosure To Announce Second-Quarter 2009 Financial Results On July 28 2Health News:Watson Confirms Filing of Abbreviated New Drug Application for Generic Sanctura XR(R) 2Health News:Intravenous Immune Biologics Will Suffer from the Pending Shift in Coverage from the Medical to the Pharmacy Benefit 2Health News:Intravenous Immune Biologics Will Suffer from the Pending Shift in Coverage from the Medical to the Pharmacy Benefit 3
The Optima III line of laparoscopic hand instruments provides a well-crafted set of instruments designed for strength and durability....
Inquire...
For use with Snap-In Snap-Out-II tip inserts. Available in five styles, the Snap-In Snap-Out-II Laparoscopic Instrument Handles offer the broadest range available....
Inquire...
Medicine Products: